Editor’s Note: This article was originally posted on Imprivata’s website.
On October 24, 2018, the “SUPPORT for Patients and Communities Act” was signed into law. As part of the sweeping bill aimed at addressing the national opioid crisis, the new federal legislation includes an electronic prescribing requirement for all controlled substance prescriptions covered under a Medicare part D prescription drug plan (or an MA–PD plan). The deadline to comply with this section of the new law is January 1, 2021. Given the challenges of aligning with these new requirements, the pressing question for all healthcare organizations becomes clear: are you ready?
News From Our Partners
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
